As of 2025-05-15, the Intrinsic Value of Induction Healthcare Group PLC (INHC.L) is (2,498.72) GBP. This INHC.L valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 9.50 GBP, the upside of Induction Healthcare Group PLC is -26,402.40%.
The range of the Intrinsic Value is (10,085.46) - (1,432.99) GBP
Based on its market price of 9.50 GBP and our intrinsic valuation, Induction Healthcare Group PLC (INHC.L) is overvalued by 26,402.40%.
Note: result may not be accurate due to the invalid valuation result of DCF model.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | (10,085.46) - (1,432.99) | (2,498.72) | -26402.4% |
| DCF (Growth 10y) | (14,203.40) - (111,484.35) | (26,141.84) | -275277.3% |
| DCF (EBITDA 5y) | (150.91) - (139.97) | (1,234.50) | -123450.0% |
| DCF (EBITDA 10y) | (1,406.40) - (1,235.28) | (1,234.50) | -123450.0% |
| Fair Value | -21.02 - -21.02 | -21.02 | -321.31% |
| P/E | (116.48) - (116.39) | (107.23) | -1228.7% |
| EV/EBITDA | 10.27 - 28.73 | 19.61 | 106.4% |
| EPV | (66.43) - (103.66) | (85.05) | -995.2% |
| DDM - Stable | (49.35) - (456.31) | (252.83) | -2761.4% |
| DDM - Multi | (258.02) - (1,897.49) | (458.22) | -4923.4% |
| Market Cap (mil) | 8.86 |
| Beta | -0.77 |
| Outstanding shares (mil) | 0.93 |
| Enterprise Value (mil) | 5.75 |
| Market risk premium | 5.98% |
| Cost of Equity | 7.40% |
| Cost of Debt | 7.00% |
| WACC | 7.39% |